Treatment goals for Friedreich ataxia include symptom management, slowing disease progression, and enhancing quality of life through multidisciplinary care. Supportive therapies address comorbidities ...

(RTTNews) - Biogen Inc. (BIIB) said that the European Commission has authorized Skyclarys (omaveloxolone) for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.

A specialist nurse to support patients with the neurological condition ataxia has started work in the South West. It is a ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted priority review to Reata Pharmaceuticals Inc.’s new drug application for omaveloxolone to ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

NEW YORK, Nov. 8, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders ...

The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

“Friedreich's ataxia is a debilitating neuromuscular disease that progressively robs patients of their mobility and independence,” said Susan Perlman, MD, Clinical Professor, Department of Neurology, ...

COLUMBIA - One Columbia woman says a newly-approved treatment for her rare neuromuscular disorder has been life changing. Skyclarys (omaveloxolone) was approved by the U.S. Food and Drug ...

SALT LAKE CITY - Scientists report a significant step toward combatting two degenerative brain diseases that chip away at an individual's ability to move, and think. A targeted therapy developed by ...

The first time Stephanie Miller heard the word “ataxia” was when she learned she had it. Now the Cleveland woman is doing what she can to slow its progression with a strong support system of family ...

The ataxia market has been anticipated to experience noteworthy growth prospects in the forthcoming years. This increasing market growth is on the back of rising cases of ataxia and a constantly ...